Interactive diabetes case 12: Perioperative management of a 67-year-old patient with type 2 diabetes who undergoes coronary artery bypass surgery – B2

ANSWER — Incorrect.

It is appropriate to address the transition to a basal dose of subcutaneous insulin as soon as possible when the decision is made to stop an intravenous insulin infusion and to begin the process of determining the insulin regimen that will be needed at the time of discharge from the hospital. It is also a good idea to plan for an overlap of the insulin infusion and the onset of action of the glargine insulin.

However, the dose of glargine insulin chosen and the sliding scale as written are unlikely to have an impact on the patient's glucose levels, based on the patient's insulin infusion rate when stable and off pressors.

Return to the previous choice to try again. (See "Interactive diabetes case 12: Perioperative management of a 67-year-old patient with type 2 diabetes who undergoes coronary artery bypass surgery – A3".)